ALBBasic Materials · Specialty ChemicalsThe 22 Wall Street analysts covering Albemarle Corp. hold a median 12-month price target of $135 — +44.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 76 of 100 as at 13 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Albemarle Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (94): Reported profit is backed by cash, and the company is not expanding recklessly.
Volatility (23): The share price moves around a lot.
Size (14): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on ALB, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +44.3% from it.
Of the 20 most recent actions, 1 moved their price target up and 11 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 9 Nov 2026 | Citigroup | Maintains | Buy | $125 → $140 |
| 9 Nov 2026 | Morgan Stanley | Maintains | Equal-Weight | $161 → $105 |
| 9 Nov 2026 | Scotiabank | Maintains | Sector Outperform | $190 → $165 |
| 9 Nov 2026 | UBS | Maintains | Buy | $150 → $137 |
| 6 Nov 2026 | Barclays | Maintains | Equal-Weight | $109 → $95 |
| 6 Nov 2026 | RBC Capital | Maintains | Outperform | $129 → $119 |
| 6 Nov 2026 | Truist Securities | Reiterates | Buy | $185 → $170 |
| 22 Oct 2026 | Citigroup | Maintains | Buy | $175 → $125 |
| 22 Oct 2026 | Citigroup | Maintains | Buy | — |
| 20 Oct 2026 | Truist Securities | Maintains | Buy | — |
| 20 Oct 2026 | Truist Securities | Maintains | Buy | $225 → $185 |
| 15 Oct 2026 | RBC Capital | Maintains | Outperform | $157 → $129 |
| 15 Oct 2026 | RBC Capital | Maintains | Outperform | — |
| 14 Oct 2026 | Mizuho | Upgrade | Outperform | $130 |
| 14 Oct 2026 | Mizuho | Upgrade | Outperform | — |
| 13 Oct 2026 | Barclays | Initiates | Equal-Weight | $109 |
| 13 Oct 2026 | Barclays | Initiates | Equal-Weight | — |
| 7 Oct 2026 | Argus Research | Maintains | Buy | $230 → $135 |
| 7 Oct 2026 | Argus Research | Maintains | Buy | — |
| 5 Oct 2026 | UBS | Maintains | Buy | $175 → $150 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
ALB appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 13 Nov 2026, Albemarle Corp. returned −17.4% against +13.4% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 33% of US stocks
Cheaper than 53% of US stocks
Cheaper than 59% of US stocks
Cheaper than 44% of US stocks
Higher than 68% of US stocks
Higher than 99% of US stocks
Higher than 40% of US stocks
Higher than 77% of US stocks
Higher than 71% of US stocks
Higher than 56% of US stocks
Higher than 70% of US stocks
Higher than 77% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Albemarle Corp. has a market value of $11.2B and an enterprise value of $13.9B.
Revenue in the twelve months to 30 June 2026: $5.9B. The latest quarter grew 18.8% year on year.
Net income over the same four quarters: $278.5M, a 4.7% net margin.
Diluted earnings per share, trailing twelve months: $0.27.
Free cash flow in the twelve months to 30 June 2026: $1.3B, after $458.0M of capital spending.
Albemarle Corp. spent $357.4M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 22.6×; forward P/E: 11.1× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 1.75%, paying out 39% of earnings.
Albemarle Corp. employs 7,800 people — $757K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Albemarle Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
The Zacks item asks whether Albemarle is a buy amid optimistic sentiment from Wall Street analysts, and questions the importance of brokerage analyst recommendations and rating-change coverage.
Why it matters — ALB watchers may find the discussion relevant when considering how analyst recommendations and media reports about rating changes factor into stock decisions.
Zacks Investment Research says Albemarle has recently attracted notable attention from users of Zacks.com and highlights the value of understanding facts that could influence the stock’s prospects.
Why it matters — The item signals increased investor attention to ALB and frames the article as a review of factors relevant to its prospects.
Albemarle beat third-quarter earnings estimates, supported by strong lithium demand, cost reductions and higher profits in its Specialties business despite volatile lithium prices.
Why it matters — The results highlight how demand, cost discipline and Specialties profits contributed to ALB’s performance amid lithium-price volatility.
Albemarle reported higher third-quarter sales and earnings, supported by stronger lithium prices and demand for bromine products. Management raised its outlook for the specialties business and reduced planned capital spending.
Why it matters — The results and updated outlook provide ALB watchers with information about business performance and the company’s spending plans.
Albemarle held its Q3 2026 earnings call on November 5, 2026. The excerpt lists company and conference-call participants and introduces the presentation operator’s handoff to Vice President of Investor Relations and Sustainability Meredith Bandy.
Why it matters — The excerpt confirms the call took place but provides no earnings results or business commentary for ALB watchers to assess.
The 22 Wall Street analysts covering Albemarle Corp. have a median 12-month price target of $135, with estimates ranging from $83 to $211. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 22 analysts covering Albemarle Corp., 14 rate it a Buy, 8 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Albemarle Corp. 76 out of 100 across roughly 4,600 US stocks as at 13 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 13 Nov 2026, Albemarle Corp. ranks 76 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (94 of 100).
No one can know that. What the data says: the median 12-month target from 22 analysts implies +44.3% from the last close, and Ticker Nerd's factor model ranks Albemarle Corp. 76 out of 100 as at 13 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Albemarle Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ALB are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $83 to $211 over the next 12 months.
Albemarle Corp. returned -17.4% over the 12 months to 13 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
Albemarle Corporation is a global specialty chemicals company focused on lithium, bromine, and catalyst solutions. Albemarle supplies critical materials used in energy storage, electric mobility, electronics, construction, agriculture, pharmaceuticals, and petroleum refining.
The most recent item we track (Zacks Investment Research, 11 Nov 2026): "Is Albemarle (ALB) a Buy as Wall Street Analysts Look Optimistic?". The Zacks item asks whether Albemarle is a buy amid optimistic sentiment from Wall Street analysts, and questions the importance of brokerage analyst recommendations and rating-change coverage.
Albemarle Corporation is a global specialty chemicals company focused on lithium, bromine, and catalyst solutions. Albemarle supplies critical materials used in energy storage, electric mobility, electronics, construction, agriculture, pharmaceuticals, and petroleum refining. Its lithium products support battery supply chains for grid storage and transportation, while its bromine specialties serve flame retardants and other industrial applications. The company’s catalysts business provides technologies used in refining and chemical processing, helping customers improve product performance and operational efficiency. Albemarle operates across multiple regions and serves a broad international customer base through its Energy Storage, Specialties, and Ketjen segments. Headquartered in Charlotte, North Carolina, Albemarle plays a significant role in the specialty materials market by transforming essential resources into ingredients used in modern industrial and consumer applications.
CEO Mr. Jerry Kent Masters Jr. · 7,800 employees · United States · https://www.albemarle.com
